publication . Article . 2012

Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV

Chio, A.; Ilardi, A.; Cammarosano, S.; Moglia, C.; Montuschi, A.; Calvo, A.;
Closed Access English
  • Published: 21 Mar 2012 Journal: NEUROLOGY (issn: 0028-3878, Copyright policy)
  • Country: Italy
Objective: To assess the effect of neurobehavioral dysfunction on amyotrophic lateral sclerosis (ALS) survival and on the use of life-prolonging therapies in a population-based setting. Methods: Of the 132 patients diagnosed with ALS in the province of Torino, Italy, between January 1, 2007, and June 30, 2008, 128 participated in the study. Neurobehavioral dysfunction was assessed with the Frontal Systems Behavior Scale (FrSBe), using the Family Rating forms, administered within 4 months from diagnosis. Results: The 128 patients included 71 men and 57 women, with a mean age at onset of 64.7 (SD 11) years. Forty-one patients (32.0%) had a neurobehavioral dysfunct...
free text keywords: amyotrophic lateral sclerosis; frontotemporal lobar degeneration, Clinical Neurology, Diabetes mellitus, medicine.disease, medicine, Population, education.field_of_study, education, Physical therapy, medicine.medical_specialty, Parenteral nutrition, Frontotemporal lobar degeneration, Amyotrophic lateral sclerosis, business.industry, business
Related Organizations
Funded by
European multidisciplinary ALS network identification to cure motor neuron degeneration
  • Funder: European Commission (EC)
  • Project Code: 259867
  • Funding stream: FP7 | SP1 | HEALTH
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue